Herbert Herzog Selected Research

Leptin

1/2022	The Effect of Dietary Fat and Sucrose on Cognitive Functioning in Mice Lacking Insulin Signaling in Neuropeptide Y Neurons.
1/2020	Leptin signalling on arcuate NPY neurones controls adiposity independent of energy balance or diet composition.
11/2018	Diet-induced obesity suppresses cortical bone accrual by a neuropeptide Y-dependent mechanism.
4/2013	Neuropeptide Y is a critical modulator of leptin's regulation of cortical bone.
2/2009	Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
9/2008	Synergistic attenuation of obesity by Y2- and Y4-receptor double knockout in ob/ob mice.
2/2008	PYY transgenic mice are protected against diet-induced and genetic obesity.
10/2005	Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
4/2002	Hypothalamic Y2 receptors regulate bone formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herbert Herzog Research Topics

Disease

35	Obesity 01/2023 - 04/2002
28	Body Weight (Weight, Body) 12/2022 - 05/2002
16	AIDS-Related Complex (ARC) 01/2023 - 04/2006
8	Weight Loss (Weight Reduction) 01/2016 - 09/2006
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
7	Insulin Resistance 04/2017 - 10/2006
6	Hyperphagia (Overeating) 01/2020 - 11/2006
5	Anorexia 12/2021 - 11/2007
5	Seizures (Absence Seizure) 09/2011 - 09/2005
4	Glucose Intolerance 01/2022 - 12/2016
4	Neoplasms (Cancer) 01/2016 - 11/2007
4	Epilepsy (Aura) 01/2012 - 04/2007
4	Weight Gain 11/2011 - 10/2005
3	Prader-Willi Syndrome (Syndrome, Prader-Willi) 04/2017 - 08/2011
3	Osteoporosis 12/2012 - 12/2009
3	Inflammation (Inflammations) 12/2012 - 11/2011
2	Cognitive Dysfunction 01/2022 - 07/2013
2	MASS syndrome 01/2020 - 03/2015
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 07/2013
2	Schizophrenia (Dementia Praecox) 03/2010 - 12/2006
2	Hyperinsulinism (Hyperinsulinemia) 11/2006 - 10/2006
2	Mood Disorders (Mood Disorder) 01/2006 - 07/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Frailty 06/2021
1	Infections 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Hyperalgesia 01/2017
1	Pain (Aches) 01/2017
1	Visceral Pain 01/2017
1	Starvation 12/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2016
1	Disease Progression 01/2016
1	Bone Diseases (Bone Disease) 01/2016
1	Hyperthermia 01/2016
1	Cachexia 01/2013

Drug/Important Bio-Agent (IBA)

29	Neuropeptide YIBA 01/2023 - 05/2002
16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2006
13	Insulin (Novolin)FDA Link 01/2022 - 10/2006
10	Peptide YYIBA 11/2021 - 09/2006
9	LeptinIBA 01/2022 - 04/2002
9	Messenger RNA (mRNA)IBA 01/2018 - 06/2002
7	Peptides (Polypeptides)IBA 01/2023 - 11/2006
7	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2023 - 06/2002
7	Dynorphins (Dynorphin)IBA 06/2014 - 04/2007
6	NeuropeptidesIBA 01/2022 - 04/2007
5	Hormones (Hormone)IBA 01/2014 - 12/2006
5	preproenkephalinIBA 01/2014 - 04/2006
4	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 12/2022 - 11/2021
3	CytokinesIBA 01/2019 - 11/2007
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014 - 04/2006
3	GhrelinIBA 01/2012 - 07/2007
3	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 12/2009 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
2	BIBO 3304IBA 11/2021 - 07/2012
2	Anabolic AgentsIBA 01/2018 - 01/2018
2	LigandsIBA 01/2017 - 06/2005
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 02/2008
2	Opioid Analgesics (Opioids)IBA 06/2014 - 04/2007
2	neuropeptide Y4 receptorIBA 12/2013 - 12/2009
2	Neuroprotective AgentsIBA 09/2012 - 09/2011
2	LipidsIBA 08/2012 - 02/2008
2	CorticosteroneIBA 07/2012 - 09/2008
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2012 - 04/2007
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 12/2009 - 03/2007
2	Kainic Acid (Kainate)IBA 04/2006 - 09/2005
1	ninjin'yoeitoIBA 06/2021
1	NeurotensinIBA 04/2020
1	MineralsIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Small Nucleolar RNA (snoRNA)IBA 04/2017
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 01/2017
1	allyl isothiocyanateIBA 01/2017
1	Peanut OilIBA 01/2017
1	trichlorosucrose (sucralose)IBA 12/2016
1	CatecholaminesIBA 12/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016
1	bone resorption factorIBA 01/2016
1	SugarsIBA 01/2016
1	Glucagon (Glukagon)FDA Link 01/2015
1	Nonesterified Fatty Acids (NEFA)IBA 01/2015
1	C-PeptideIBA 01/2015
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2014
1	cocaine- and amphetamine-regulated transcript proteinIBA 01/2014
1	Dimenhydrinate (DMH)FDA LinkGeneric 12/2013
1	KynurenineIBA 11/2013
1	Homer Scaffolding Proteins (Homer 1)IBA 07/2013
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 07/2013
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 02/2013
1	Uncoupling Protein 1IBA 02/2013
1	Insulin Receptor Substrate ProteinsIBA 12/2012
1	Opiate AlkaloidsIBA 12/2012
1	Insulin ReceptorIBA 12/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2012

Therapy/Procedure

6	Therapeutics 12/2018 - 11/2003
1	Glycemic Control 01/2022
1	Islets of Langerhans Transplantation 01/2022
1	Kampo Medicine (Kampo) 06/2021